USFDA Reappoints Vinay Prasad to Top Medical and Scientific Role
Advertisement
New Delhi: Vinay Prasad has regained his role as the U.S. Food and Drug Administration's chief medical and scientific officer, according to an update on the health agency's website.
Last month, Prasad returned to his role overseeing vaccine, gene therapy and blood product regulation at the FDA, a little more than a week after he left. Medical Dialogues team had earlier reported that a spokesperson from the Department of Health and Human Services had stated, “Dr. Prasad did not want to be a distraction to the great work of the FDA … and has decided to return to California and spend more time with his family.”
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.